Balaxi Pharmaceuticals consolidated net profit rises 32.12% in the June 2022 quarter

2 Aug 2022 , 03:58 PM

Net profit of Balaxi Pharmaceuticals rose 32.12% to Rs 14.15 crore in the quarter ended June 2022 as against Rs 10.71 crore during the previous quarter ended June 2021. Sales rose 41.89% to Rs 82.78 crore in the quarter ended June 2022 as against Rs 58.34 crore during the previous quarter ended June 2021.

Particulars	Quarter Ended
?	Jun. 2022	Jun. 2021	% Var.
Sales	82.78	58.34	42
OPM %	16.61	19.52	–
PBDT	16.84	12.56	34
PBT	16.65	12.49	33
NP	14.15	10.71	32

Powered by Capital Market – Live News